Multiple Myeloma in Relapse Terminated Phase 1 Trials for Pomalidomide (DB08910)
Indication | Status | Phase |
---|---|---|
DBCOND0036092 (Multiple Myeloma in Relapse) | Terminated | 1 |
clinicaltrials.gov Identifier | Title | Purpose | Drugs |
---|---|---|---|
NCT01889420 | Phase I Trial of Everolimus, Pomalidomide and Dexamethasone in Patients With Relapsed/Refractory Multiple Myeloma | Treatment |